Quality of administration of intranasal steroid sprays in patient in rhinology clinic in HRH Princess Maha Chakri Sirindhorn Medical Center

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210718003

Enrollment

150

Registered

2021-07-18

Start date

2020-07-18

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of administration of intranasal steroid sprays Intranasal steroid Quality of administration Allergic rhinitis

Interventions

1. Allergic rhinitis 2. Chronic rhinosinusitis with out nasal polyp 3. Chronic rhinosinusitis with nasal polyp

Health Services Research

Patient using intranasal steroid

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years 2. Confirm diagnosis of Allergic rhinitis, Chronic rhinosinusitis with out nasal polyp, Chronic rhinosinusitis with nasal polyp in HRH Princess Maha Chakri Siridhorn Medical Center 3. Use intranasal steroid for more than 1 week

Exclusion criteria

Exclusion criteria: 1. Unable to communicate in thai language 2. Allergy to intranasal steroid 3. Contraindicated for intranasal steroid use ex. glaucoma, pulmonary tuberculosis, fungal infection 4. Pregnancy

Design outcomes

Primary

Measure	Time frame
Quality of administration of intranasal steroid sprays At least 1 week after using intranasal steroid 12 step for using intranasal steroid	—

Secondary

Measure	Time frame
complication after using intranasal steroid within one year after start using intranasal steroid number of patients with complications	—

Countries

Thailand

Contacts

Public Contactpanuwat wongwattana

Srinakharinwirot university

panuwatw@g.swu.ac.th0909691366

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026